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The study of indoor environmental quality as well as the development and progression of chronic respiratory 
diseases have received a great deal of attention in the past few years. However, most of those surveys focus on 
the effects of particulate matter (PM) and biological contaminants (fungi and bacteria) and evidences on the ef-
fects of endocrine disrupting chemicals (EDCs) in these pathologies are limited. Hence, RESPIRA project aims to 
contribute towards a better understanding of the role of multiple stressors in respiratory diseases by providing 
data on the levels and effects of EDCs in patients with Chronic Obstructive Pulmonary Disease (COPD) and con-
trol individuals from Estarreja region (NW Portugal). Here we will summarize the results obtained for phenolic 
compounds (parabens, triclosan and triclocarban) in matched human and indoor environmental samples (hou-
se dust) from COPD patients. Overall, the concentrations in dust samples are one to two orders of magnitude 
higher that the concentrations in human urine. Triclosan was detected in all the dust samples, triclocarban was 
detected in 82% of the dust samples and parabens in 90% to 100% of the samples. In urine samples, triclosan 
was detected in 56% of the samples, triclocarban was always bellow detection limit (0.25 ng/mL) and parabens 
detection frequency varied widely (23-84%). Interestingly, the highest level reported in dust for triclosan (1200 
ng/g) corresponded to the house of the patient with the highest triclosan concentration in urine (140 ng/mL). 
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